Lipidomic profiling of human bile distinguishes cholangiocarcinoma from benign bile duct diseases with high specificity and sensitivity: a prospective descriptive study

This study not only identified lipidomic alterations in CCA using bile samples but also established and validated a bile lipid classifier with high specificity and sensitivity for distinguishing between CCA and benign bile duct diseases. Our findings highlight the potential of bile lipid biomarkers for improving the differential diagnosis and risk assessment of CCA and preventing potential overintervention in patients with benign biliary disease.

Authors

Institutions

Publication Details

Journal
British Journal of Cancer
Published
2025-09-02
DOI
https://doi.org/10.1038/s41416-025-03144-9
Citations
3
Primary Topic
Cholangiocarcinoma and Gallbladder Cancer Studies
Type
article
Field-Weighted Citation Impact
6.02

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Lipidomic profiling of human bile distinguishes cholangiocarcinoma from benign bile duct diseases with high specificity and sensitivity: a prospective descriptive study

Xiaomian Li, Yufeng Yuan, Yuan Tao, Ming-He Zhang et al.
3 citations
British Journal of Cancer
Cholangiocarcinoma and Gallbladder Cancer Studies
6.02
article

Lipidomic profiling of human bile distinguishes cholangiocarcinoma from benign bile duct diseases with high specificity and sensitivity: a prospective descriptive study

Xiaomian Li, Yufeng Yuan, Yuan Tao, Ming-He Zhang, Wei‐Hua Huang, Weijie Ma, Bo Liao, Xiaoyu Pan, Xi Chen, Jinghua Li, Ping Jiang, Fusheng Liu, Shikun Zhang, Junyu Zhou, Yingyi Liu, Shan Guo, Wei-Xian Fang, Xu-Yun Yan, Yi-Bo Chai, Tiangen Wu, Song-Mei Liu
article en
3 citations

Abstract

This study not only identified lipidomic alterations in CCA using bile samples but also established and validated a bile lipid classifier with high specificity and sensitivity for distinguishing between CCA and benign bile duct diseases. Our findings highlight the potential of bile lipid biomarkers for improving the differential diagnosis and risk assessment of CCA and preventing potential overintervention in patients with benign biliary disease.

British Journal of CancerVol. 133(10)
Wuhan University (CN), Zhongnan Hospital of Wuhan University (CN), Hubei University (CN)
Wuhan University, Zhongnan Hospital of Wuhan University
Openalex Percentile: Top 4%
Cholangiocarcinoma and Gallbladder Cancer Studies
6.02
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.